| MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells YZ Pan, ME Morris, AM Yu Molecular pharmacology 75 (6), 1374-1379, 2009 | 377 | 2009 |
| MicroRNAs regulate CYP3A4 expression via direct and indirect targeting YZ Pan, W Gao, AM Yu Drug metabolism and disposition 37 (10), 2112-2117, 2009 | 317 | 2009 |
| Application of physiologically based pharmacokinetic (PBPK) modeling to support dose selection: report of an FDA public workshop on PBPK C Wagner, P Zhao, Y Pan, V Hsu, J Grillo, SM Huang, V Sinha CPT: pharmacometrics & systems pharmacology 4 (4), 226-230, 2015 | 282 | 2015 |
| FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase–positive non–small cell lung cancer S Khozin, GM Blumenthal, L Zhang, S Tang, M Brower, E Fox, W Helms, ... Clinical cancer research 21 (11), 2436-2439, 2015 | 206 | 2015 |
| miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes AE Bruno, L Li, JL Kalabus, Y Pan, A Yu, Z Hu BMC genomics 13, 1-7, 2012 | 193 | 2012 |
| Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328,-519c and-520h) and their differential expression in stem-like ABCG2+ cancer cells X Li, YZ Pan, GM Seigel, ZH Hu, M Huang, AM Yu Biochemical pharmacology 81 (6), 783-792, 2011 | 161 | 2011 |
| Predicting the effect of cytochrome P450 inhibitors on substrate drugs: analysis of physiologically based pharmacokinetic modeling submissions to the US Food and Drug … C Wagner, Y Pan, V Hsu, JA Grillo, L Zhang, KS Reynolds, V Sinha, ... Clinical pharmacokinetics 54, 117-127, 2015 | 134 | 2015 |
| Predicting the effect of CYP3A inducers on the pharmacokinetics of substrate drugs using physiologically based pharmacokinetic (PBPK) modeling: an analysis of PBPK submissions … C Wagner, Y Pan, V Hsu, V Sinha, P Zhao Clinical pharmacokinetics 55, 475-483, 2016 | 95 | 2016 |
| Predictive performance of physiologically based pharmacokinetic models for the effect of food on oral drug absorption: current status M Li, P Zhao, Y Pan, C Wagner CPT: pharmacometrics & systems pharmacology 7 (2), 82-89, 2018 | 88 | 2018 |
| Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1 YZ Pan, A Zhou, Z Hu, AM Yu Drug Metabolism and Disposition 41 (10), 1744-1751, 2013 | 82 | 2013 |
| Noncoding microRNAs: small RNAs play a big role in regulation of ADME? AM Yu, YZ Pan Acta Pharmaceutica Sinica B 2 (2), 93-101, 2012 | 66 | 2012 |
| MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines AC Rodrigues, X Li, L Radecki, YZ Pan, JC Winter, M Huang, AM Yu Biopharmaceutics & drug disposition 32 (6), 355-367, 2011 | 65 | 2011 |
| Application of surface‐enhanced laser desorption/ionization time‐of‐flight‐based serum proteomic array technique for the early diagnosis of prostate cancer YZ Pan, XY Xiao, D Zhao, L Zhang, GY Ji, Y Li, BX Yang, DC He, XJ Zhao Asian journal of andrology 8 (1), 45-51, 2006 | 64 | 2006 |
| Haptoglobin‐β chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer S Saito, Y Murayama, Y Pan, T Taima, T Fujimura, K Murayama, ... International journal of cancer 123 (3), 633-640, 2008 | 61 | 2008 |
| N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed … HC Bi, YZ Pan, JX Qiu, KW Krausz, F Li, CH Johnson, CT Jiang, ... Carcinogenesis 35 (10), 2264-2272, 2014 | 55 | 2014 |
| Mass screening of 12 027 elderly men for prostate carcinoma by measuring serum prostate specific antigen H Zhang, H Wang, N Xu, SW Li, GY Ji, XM Li, YZ Pang, L Zhang, XJ Zhao, ... CHINESE MEDICAL JOURNAL-BEIJING-ENGLISH EDITION- 117 (1), 67-70, 2004 | 52 | 2004 |
| The application of physiologically based pharmacokinetic modeling to predict the role of drug transporters: scientific and regulatory perspectives Y Pan, V Hsu, M Grimstein, L Zhang, V Arya, V Sinha, JA Grillo, P Zhao The Journal of Clinical Pharmacology 56, S122-S131, 2016 | 50 | 2016 |
| MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis MJ Tu, YZ Pan, JX Qiu, EJ Kim, AM Yu Oncotarget 7 (29), 45547, 2016 | 46 | 2016 |
| Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen HW Gao, YL Li, S Wu, YS Wang, HF Zhang, YZ Pan, L Zhang, H Tateno, ... Asian journal of andrology 7 (2), 159-163, 2005 | 40 | 2005 |
| Predictive performance of physiologically-based pharmacokinetic models in predicting drug–drug interactions involving enzyme modulation CH Hsueh, V Hsu, Y Pan, P Zhao Clinical Pharmacokinetics 57, 1337-1346, 2018 | 19 | 2018 |
Christian WagnerMerck Healthcare KGaAVerified email at merckgroup.com
